

Skinvisible, Inc.
Develops topical and transdermal products made with its patented skin delivery system, Invisicare®, and filed a provisional patent for a transdermal obesity medication delivery method.
Research library
WallStreet Research has published hundreds of reports over five decades, distributed to over 200,000 investor subscribers worldwide. These are the reports and profiles featured online, covering emerging growth companies on NASDAQ, NYSE, AMEX, OTC Markets, TSX, CSE and global exchanges.


Develops topical and transdermal products made with its patented skin delivery system, Invisicare®, and filed a provisional patent for a transdermal obesity medication delivery method.


A global leader in embedded software and products for the Internet of Things, offering Android based smart connected devices, 5G and end to end cloud services.


Develops proprietary technology that changes how video is streamed, consumed, transferred and stored, including advanced video compression and portable hardware systems.


A global cannabis cultivation, extraction, distribution and branded product company with expertise across all major cannabis manufacturing processes.

A development-stage biotechnology company developing adult stem cell therapies for neurodegenerative diseases such as Parkinson's, ALS and multiple sclerosis. Its NurOwn technology, licensed from Tel Aviv University, turns a patient's own bone marrow stem cells into neural-like cells.
WallStreet Research provides research services to publicly traded companies on a fee basis, the nature and amount of which is fully disclosed in each report. Read the Disclaimer